Congress Materials From the American Epilepsy Society (AES)

Catalyst Pharmaceuticals Medical Information provides congress materials to HCPs for FYCOMPA® (perampanel), FIRDAPSE® (amifampridine), and AGAMREE® (vamorolone) oral suspension 40 mg/mL

Results for AES

The information on this page is relevant to specific congresses and disease areas and is not intended to be a comprehensive overview of any one congress or disease area.

Congress materials may include information for which the product is not approved and/or that is inconsistent with the product uses described in the Prescribing Information. Catalyst Pharmaceuticals does not suggest or recommend the use of Catalyst Pharmaceuticals products in any manner other than as described in the Prescribing Information.

Loading results…

Find medical information

Click the button below to search Catalyst medical information

Search Medical Information

Connect with your MSL

Connect with a Catalyst Pharmaceuticals MSL in your area

Locate Your MSL